Annexure 2:
MOOSE guidelines for meta-analyses and systematic reviews of observational studies.
| Topic | Page number | |
| Title | Identify the study as a meta-analysis (or systematic review) | 1 |
| Abstract | Use the journal’s structured format Introduction | 1 |
| Introduction | The clinical problem | 2 |
| The hypothesis | 2 | |
| A statement of objectives that includes the study population, the condition of interest, the exposure or intervention, and the outcome (s) considered | 2 | |
| Sources | Qualifications of searchers (e.g., librarians and investigators) | 3 |
| Search strategy, including the time period included in the synthesis and keywords | 3 | |
| Effort to include all available studies, including contact with authors | 3 | |
| Databases and registries searched | 3 | |
| Search software used, name and version, including special features used (e.g. explosion) | 4 | |
| Use of hand searching (e.g., reference lists of obtained articles) | 3 | |
| List of citations located and those excluded, including justification | 4 | |
| Method of addressing articles published in languages other than English | NA | |
| Method of handling abstracts and unpublished studies | 3 | |
| Description of any contact with authors | 3 | |
| Study Selection | Types of study designs considered | 3 |
| Relevance or appropriateness of studies gathered for assessing the hypothesis to be tested | 3 | |
| Rationale for the selection and coding of data (e.g., sound clinical principles or convenience) | 3 | |
| Documentation of how data were classified and coded (e.g., multiple raters, blinding, and inter-rater reliability) | 3 | |
| Assessment of confounding (e.g. comparability of cases and controls in studies where appropriate) | NA | |
| Assessment of study quality, including blinding of quality assessors; stratification or regression on possible predictors of study results | 4 | |
| Assessment of heterogeneity | 4 | |
| Statistical methods (e.g. complete description of fixed or random effects models, justification of whether the chosen models account for predictors of study results, dose-response models, or cumulative meta-analysis) in sufficient detail to be replicated | 4 | |
| Results | A graph summarising individual study estimates and the overall estimate | Figure 2 |
| A table giving descriptive information for each included study | Table 1 | |
| Results of sensitivity testing (e.g. subgroup analysis) | Supplementary file | |
| Indication of statistical uncertainty of finding | 4 | |
| Discussion | Strengths and weakness | 13 |
| Potential biases in the review process (e.g. publication bias) | Figure 7 | |
| Assessment of quality of included studies | 7 | |
| Consideration of alternative explanations for observed results | 12 | |
| Generalisation of the conclusions (i.e. appropriate for the data presented and within the domain of the literature review) | 13 | |
| Guidelines for future research | 13 | |
| Disclosure of funding source | ||